Adam Fine, Windham Venture Partners

Adam Fine is the Co-Founder, General Partner, and CEO of Windham Venture Partners. See sector focus and contact routes.

About Adam Fine

Adam Fine is the Co-Founder, General Partner, and CEO of Windham Venture Partners, a New York-based venture capital firm he established in 2006 with nearly two decades of prior experience in healthcare investing and medical technology. His investment thesis targets early-stage healthcare companies, specifically focusing on Seed and Series A rounds in the medical technology and digital health sectors. The firm typically writes checks between $1 million and $5 million, with Adam Fine often serving as the lead partner on deals, having led 19 transactions to date. Notable portfolio companies in his network include NeuSpera Medical, Personal Genome Diagnostics, Cureatr, and Cartiva, reflecting the firm’s focus on category-defining health products. Fine brings deep operational expertise from his previous roles as Vice President and General Manager at I-many and in business development at Cordis and Biosense, where he worked closely with Johnson & Johnson’s venture arm. While specific public writing is not detailed in the available sources, his distinctive point of view centers on backing visionary leaders at the intersection of medical technology and digital

Adam Fine at a glance

Role
Co-Founder, General Partner & CEO
Organization
Windham Venture Partners
Location
New York, New York, United States
Investor type
Venture Capital
Focus areas
Healthcare

Frequently asked about Adam Fine

What does Adam Fine invest in?
Adam Fine at Windham Venture Partners (New York, New York, United States) — sector focus: Healthcare.
How do I contact Adam Fine?
Adam Fine's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Adam Fine based?
Adam Fine is based in New York, New York, United States.

Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.

Investors similar to Adam Fine (24)

Browse related investor lists (6)

Compare Adam Fine (8)

Investors like Adam Fine · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades